Access Bio CareStart Rapid Antigen Test

Access Bio

Access Bio CareStart Rapid Antigen Test

SKU: 550564
MFG Part #: RCHM-02071
  • The Ultimate POC Test With Reliable Results Within Minutes
  • No equipment required & FDA Emergency Use Authorization
  • Minimally invasive specimen collection (nasopharyngeal swabs)
  • Detect SARS-CoV-2 nucleocapsid protein antigen
  • Identify acute infection with 88.4% sensitivity and 100% specificity
    True Know-How
    Ask our experts
    Out of Stock
    Free Shipping
    Usually ships in 1 - 3 Days
    This product is non-returnable

    $450.00 20 Test / Kit


    The CareStart COVID-19 Antigen Test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within the first five days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.

    Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high, or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., inpatient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

    NOTE: For Serial Screening of asymptomatic individuals. The serial screening indication is only applied to products manufactured by Access Bio Inc. after April 12, 2021. The product batches listed in the Official Notification Letter (click to see) should not be marketed or used for POC serial screening purposes.


    AMA CPT Codes

    Fact Sheet for Healthcare Providers

    FDA EUA Letter

    Fact Sheet for Patients

    Package Insert



    • Rapid results in 10 minutes
    • Stand-alone test kit with no equipment needed
    • Designed for use in point-of-care settings
    • Detect SARS-CoV-2 nucleocapsid protein antigen
    • Lateral flow assay
    • Minimally invasive specimen collection (nasopharyngeal)

    Product Specifications and Resources

    Sensitivity 88.4%
    Specificity 100%
    width 3"
    Height 8"
    Depth 6"
    What's in the Box
  • 20 Test devices
  • 20 Assay buffer
  • 20 Extraction vials and Caps
  • 20 Specimen Collection swabs
  • 1 Positive and negative control swabs
  • 1 Instructions for use.
    Documents & Resources

    Customers Also Bought



    Recently viewed